Vir Biotechnology (VIR) Price to FCF (2019 - 2026)
Powered by 
Analysis
Vir Biotechnology (VIR) Price to FCF (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Vir Biotechnology | 1.93 Bn | 1.93 Bn | 238.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.98 |
| Mar 31, 2026 | -10.88 |
| Dec 31, 2025 | -32.07 |
| Sep 30, 2025 | -4.73 |
| Jun 30, 2025 | -5.70 |
| Mar 31, 2025 | -11.22 |
| Dec 31, 2024 | -11.22 |
| Sep 30, 2024 | -5.88 |
| Jun 30, 2024 | -15.48 |
| Mar 31, 2024 | -12.37 |
| Dec 31, 2023 | -12.39 |
| Sep 30, 2023 | -7.90 |
| Jun 30, 2023 | -8.26 |
| Mar 31, 2023 | -23.49 |
| Dec 31, 2022 | 149.53 |
| Sep 30, 2022 | 25.93 |
| Jun 30, 2022 | 3.59 |
| Mar 31, 2022 | 6.37 |
| Dec 31, 2021 | -1,022.29 |
| Sep 30, 2021 | -50.92 |